Board of Directors

Savara Pharmaceuticals / About Savara / Board of Directors

Rob Neville


Mr. Neville is one of the founders of Savara and has served as CEO and President since 2008. Prior to Savara, Mr. Neville was founder and CEO of Evity, Inc., which was acquired by BMC in 2000. Based on his work at Evity and Savara, Mr. Neville was honored as a two-time finalist for the Ernst & Young Entrepreneur of the Year award. As managing director of Clockwise Consulting, he partnered with the Texas Children’s Hospital and the Baylor College of Medicine to develop ICU-based monitoring and diagnostic devices. Mr. Neville holds a post-graduate Engineering degree from the University of Natal South Africa.

Nevan Elam

Board Member

Mr. Elam is a former member of the executive management team of Nektar Therapeutics where he served as Senior Vice President of the Pulmonary Business Unit. In this role, he oversaw all pulmonary business including research and development, manufacturing and strategic partnerships. Mr. Elam was responsible for the sale of Nektar’s pulmonary business to Novartis for $115 million in 2008. Mr. Elam is currently Chairman, CEO and President, AntriaBio, Inc. 

Richard J. Hawkins

Board Member

Mr. Hawkins founded Pharmaco in 1983 and as Chairman, President and CEO, he facilitated the growth of the company to over 700 employees. Mr. Hawkins later served in various capacities in numerous startup companies, including Sensus Drug Development Corporation, Covance Biotechnology Services and LoopOne. He currently serves as President, Chief Executive Officer and Chairman of more than one company including LabNow.

Yuri Pikover

Board Member

Mr. Pikover is a Managing Director of 37 Ventures, a boutique venture fund focusing on growing early-stage startups, and serves on boards of various companies. From 1993-2008, Mr. Pikover founded and held executive roles in Xylan, Access360, 5square, Folsom Lake Nissan, and served on boards of several dozen companies. Prior to 1993, Mr. Pikover held technical and management positions with Micom Systems and Fibermux Corporation.

Joseph S. McCracken

Board Member

Dr. McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. Most recently he was Global Head for Business Development & Licensing at Roche Pharma, where he was responsible for Roche Pharma’s global in-licensing and out-licensing activities. Prior to joining Roche Pharma, Dr. McCracken held the position of Vice President, Business Development at Genentech for more than 10 years.

Back to Top